Q3 FY26 results: Revenue up 21% YoY; Rs 160 interim dividend declared

Revenue Growth 20pctExceptional ItemResults View source PDF Explain this filing

PGHL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.1%Reaction day

₹5235.00

prior close

₹5190.00

announcement price

In-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-0.8%-0.3% vs market

Pharmaceuticals peers, median of 159sector-0.6%-0.5% vs sector

On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250 and 0.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

-0.1

15m

-0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.1-0.8-0.3-0.6-0.5

Next day

+2.8+1.8+1.0+1.1+1.6

+5.3+2.8+2.5+1.7+3.6

+4.7+2.3+2.4+1.3+3.4

-1.1+1.8-2.8+0.7-1.7

-3.9+0.3-4.2+0.0-4.0

-2.9+0.5-3.4-0.2-2.7

15d

-5.9-2.5-3.4-2.3-3.6

-6.7-6.3-0.4-4.4-2.4

-8.2-8.0-0.3-7.2-1.0

+2.2+8.3-6.0+2.7-0.5

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 159Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q3 FY26 revenue rose 20.7% YoY to Rs 37,386 lakhs. Net profit fell 14.6% to Rs 7,759 lakhs. For 9M FY26, revenue grew 14.4% to Rs 1,03,752 lakhs and net profit rose 22.3% to Rs 23,231 lakhs. Board declared interim dividend of Rs 160 per share, including a one-time special dividend of Rs 50. Record date Feb 12; payment by Mar 4.

Likely market impact

Positive: strong Q3 revenue growth and generous dividend with a one-time special component. Q3 profit dip is a concern but 9M profit is up strongly.